Allergic conjunctivitis in children: from pathogenesis to therapy


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅存取

详细

In the article data about classification, pathogenesis, clinical manifestations and treatment of different forms of allergic conjunctivitis in children are presented.

作者简介

N Leppenen

Moscow Institute of Pediatrics and Child Surgery of Ministry of Health & Social Welfare of Russian Federation

A Pampura

Moscow Institute of Pediatrics and Child Surgery of Ministry of Health & Social Welfare of Russian Federation

Email: apampura@pedklin.ru

参考

  1. Ono S.J., Abelson M.B. Allergic conjunctivitis: update on pathophysiology and prospects for future treatment. J. Allergy Clin. Immunol. 2005, v. 115, p. 118-122.
  2. Levin L.A., Albert D.M. Ocular Disease: Mechanisms and Management. Saunders. 2010, p. 687.
  3. Bonini S., Sgrulletta R., Coassin M., Bonini S. Allergic Conjunctivitis: Update on Its Pathophysiology and Perspectives for Future Treatment. in R. Pawankar et al. Allergy Frontiers: Clinical Manifestations. Springer. 2009, p. 25-47.
  4. Leonardi A., Busca F., Motterle L. et al. Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study. Acta Ophthalmol. Scand. 2006, v. 84, p. 406-410.
  5. Irani A.M., Butrus S.I., Tabbara K.F., Schwartz L.B. Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin. Immunol. 1990, v. 86, p. 34-40.
  6. Anderson D.F., MacLeod J.D., Baddeley S.M. et al. Seasonal allergic conjunctivitis is accompanied by increased mast cell numbers in the absence of leukocyte infiltration. Clin. Exp. Allergy. 1997, v. 27, p. 1060-1066.
  7. Ono S.J. Vernal keratoconjunctivitis: evidence for immunoglobulin E-dependent and immunoglobulin E-independent eosinophilia. Clin. Exp. Allergy. 2003, v. 33, p. 279-281.
  8. Trocme S.D., Kephart G.M., Bourne W.N. et al. Eosinophil granule major basic protein deposition in corneal ulcers associated with vernal keratoconjunctivtis. Am. J. Ophthalmol. 1993, v. 115, p. 640-643.
  9. Tanaka M., Dogru M., Takano Y et al. The relation ofconjunc-tival and corneal findings in severe ocular allergies. Cornea. 2004, v. 23, p. 464-467.
  10. Майчук Ю.Ф., Ковалевская М.А., Бржеский В.В. и соавт. Синдром «красного глаза». Практическое руководство для врачей-офтальмологов. М., 2010, с. 82-83.
  11. Kanski J.J. Clinical Ophthalmology. 6th edition. Oxford: But-terworth-Hienemann. 2007.
  12. Hogan M.J. Atopic keratoconjunctivitis. Am. J. Ophthalmol. 1953, v. 36, p. 937-947.
  13. Bielory L., Lien K.W, Bigelsen S. Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs. 2005, v. 65 (2), p. 215-228.
  14. Leonardi A., Zafirakis P. Efficacy and comfort of olopatadine versus ketotifen ophthalmic solutions: A double-masked, environmental study of patient preference. Curr. Med. Res. Opin. 2004, v. 20 (8), p. 1167-1173.
  15. Rosenwasser L.J., O’Brien T, Weyne J. Mast cell stabilization and antihistamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research. Curr. Med. Res. Opin. 2005, v. 21 (9), p. 1377-1378.
  16. Майчук Ю.Ф., Позднякова В.В., Якушина Л.Н. Опатанол (олопатадин 0,1%) в лечении аллергических заболеваний глаз. РМЖ. 2007, т. 8, № 2, с. 63-67.

版权所有 © Pharmarus Print Media, 2012

##common.cookie##